These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 19787769)

  • 41. Mutations for the people.
    Kristensen V; Borresen-Dale AL
    EMBO Mol Med; 2010 May; 2(5):143-5. PubMed ID: 20461736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in mutational processes and intra-tumour heterogeneity between organs: The local selective filter hypothesis.
    Giraudeau M; Sepp T; Ujvari B; Renaud F; Tasiemski A; Roche B; Capp JP; Thomas F
    Evol Med Public Health; 2019; 2019(1):139-146. PubMed ID: 31528343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Edgetic perturbation models of human inherited disorders.
    Zhong Q; Simonis N; Li QR; Charloteaux B; Heuze F; Klitgord N; Tam S; Yu H; Venkatesan K; Mou D; Swearingen V; Yildirim MA; Yan H; Dricot A; Szeto D; Lin C; Hao T; Fan C; Milstein S; Dupuy D; Brasseur R; Hill DE; Cusick ME; Vidal M
    Mol Syst Biol; 2009; 5():321. PubMed ID: 19888216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Docking-based approach for identification of mutations that disrupt binding between Bcl-2 and Bax proteins: Inducing apoptosis in cancer cells.
    Raghav PK; Kumar R; Kumar V; Raghava GPS
    Mol Genet Genomic Med; 2019 Nov; 7(11):e910. PubMed ID: 31490001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is cell migration a selectable trait in the natural evolution of cancer development?
    Disanza A; Bisi S; Frittoli E; Malinverno C; Marchesi S; Palamidessi A; Rizvi A; Scita G
    Philos Trans R Soc Lond B Biol Sci; 2019 Aug; 374(1779):20180224. PubMed ID: 31431177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A CATH domain functional family based approach to identify putative cancer driver genes and driver mutations.
    Ashford P; Pang CSM; Moya-García AA; Adeyelu T; Orengo CA
    Sci Rep; 2019 Jan; 9(1):263. PubMed ID: 30670742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deriving a mutation index of carcinogenicity using protein structure and protein interfaces.
    Espinosa O; Mitsopoulos K; Hakas J; Pearl F; Zvelebil M
    PLoS One; 2014; 9(1):e84598. PubMed ID: 24454733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disease-related mutations predicted to impact protein function.
    Schaefer C; Bromberg Y; Achten D; Rost B
    BMC Genomics; 2012 Jun; 13 Suppl 4(Suppl 4):S11. PubMed ID: 22759649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human genomic disease variants: a neutral evolutionary explanation.
    Dudley JT; Kim Y; Liu L; Markov GJ; Gerold K; Chen R; Butte AJ; Kumar S
    Genome Res; 2012 Aug; 22(8):1383-94. PubMed ID: 22665443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incorporating molecular and functional context into the analysis and prioritization of human variants associated with cancer.
    Peterson TA; Nehrt NL; Park D; Kann MG
    J Am Med Inform Assoc; 2012; 19(2):275-83. PubMed ID: 22319177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors.
    Stehr H; Jang SH; Duarte JM; Wierling C; Lehrach H; Lappe M; Lange BM
    Mol Cancer; 2011 May; 10():54. PubMed ID: 21575214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Germline fitness-based scoring of cancer mutations.
    Fischer A; Greenman C; Mustonen V
    Genetics; 2011 Jun; 188(2):383-93. PubMed ID: 21441214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural and functional restraints on the occurrence of single amino acid variations in human proteins.
    Gong S; Blundell TL
    PLoS One; 2010 Feb; 5(2):e9186. PubMed ID: 20169194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Somatic mutations and genetic polymorphisms of the PPP1R3 gene in patients with several types of cancers.
    Takakura S; Kohno T; Shimizu K; Ohwada S; Okamoto A; Yokota J
    Oncogene; 2000 Feb; 19(6):836-40. PubMed ID: 10698503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
    de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
    Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypothesis on a casual link between EMF and an evolutionary class of cancer and spontaneous abortion.
    Cooper WG
    Cancer Biochem Biophys; 1996 Apr; 15(3):151-70. PubMed ID: 8937739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The (non)malignancy of cancerous amino acidic substitutions.
    Talavera D; Taylor MS; Thornton JM
    Proteins; 2010 Feb; 78(3):518-29. PubMed ID: 19787769
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective pressures at a codon-level predict deleterious mutations in human disease genes.
    Arbiza L; Duchi S; Montaner D; Burguet J; Pantoja-Uceda D; Pineda-Lucena A; Dopazo J; Dopazo H
    J Mol Biol; 2006 May; 358(5):1390-404. PubMed ID: 16584746
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.